Can a CRO identify study sites for a clinical trial?
Yes — and at Biostat®, this is one of our strongest operational capabilities.
Finding, evaluating and activating study sites is critical to study success. Poor site selection often leads to recruitment challenges, missing data and delays.
Biostat® continually develops its own network of cooperating sites across Poland, enabling rapid study launch and strong recruitment performance.
Our network includes:
• major university and clinical hospitals,
• Clinical Research Support Centers,
• specialised clinics and outpatient centres,
• private practice sites ideal for observational studies,
• smaller regional sites known for excellent recruitment results.
New sites join our network regularly, and we continuously update information on their infrastructure, staff and patient profile.
How does the site selection and activation process work?
During feasibility, we assess:
• patient population availability,
• investigators’ experience,
• technical infrastructure,
• current project load,
• historical recruitment performance.
We then prepare a list of recommended sites with documented recruitment potential.
After sponsor approval, we contact investigators, collect participation confirmations and negotiate contracts.
We also organise:
• investigator meetings,
• GCP trainings,
• and kick-off meetings before site initiation visits.
This ensures smooth startup and efficient early recruitment.
